[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Active Pharmaceutical Ingredients(API) Market Report 2017

October 2017 | 119 pages | ID: UE39F6C5A1CEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Active Pharmaceutical Ingredients(API) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Active Pharmaceutical Ingredients(API) in these regions, from 2012 to 2022 (forecast).
United States Active Pharmaceutical Ingredients(API) market competition by top manufacturers/players, with Active Pharmaceutical Ingredients(API) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
  • Novartis International
  • Sanofi
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Teva Pharmaceutical
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Merck & Co
  • AbbVie
  • Johnson & Johnson
  • Bayer
  • Sun Pharmaceutical Industries
  • DSM
  • Hisun Pharmacy
  • Huahai Pharmaceutical
  • North China Pharmaceutical Group
  • Shandong Lukang Pharmaceutical
  • Haerbin Pharmaceutical Group
  • Shandong Xinhua Pharmaceutical
  • Jiangsu Hengrui Medicine
  • Lonza Group
  • Aurobindo Pharma
  • Lupin
  • Biocon
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Synthetic APIs
  • Biotech APIs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Active Pharmaceutical Ingredients(API) for each application, including
  • Oncology
  • Diabetes
  • Cardiovascular Disease
  • CNS and Neurological Disorders
  • Endocrinology
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Active Pharmaceutical Ingredients(API) Market Report 2017

1 ACTIVE PHARMACEUTICAL INGREDIENTS(API) OVERVIEW

1.1 Product Overview and Scope of Active Pharmaceutical Ingredients(API)
1.2 Classification of Active Pharmaceutical Ingredients(API) by Product Category
  1.2.1 United States Active Pharmaceutical Ingredients(API) Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Active Pharmaceutical Ingredients(API) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Synthetic APIs
  1.2.4 Biotech APIs
1.3 United States Active Pharmaceutical Ingredients(API) Market by Application/End Users
  1.3.1 United States Active Pharmaceutical Ingredients(API) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Oncology
  1.3.3 Diabetes
  1.3.4 Cardiovascular Disease
  1.3.5 CNS and Neurological Disorders
  1.3.6 Endocrinology
  1.3.7 Other
1.4 United States Active Pharmaceutical Ingredients(API) Market by Region
  1.4.1 United States Active Pharmaceutical Ingredients(API) Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Active Pharmaceutical Ingredients(API) Status and Prospect (2012-2022)
  1.4.3 Southwest Active Pharmaceutical Ingredients(API) Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Active Pharmaceutical Ingredients(API) Status and Prospect (2012-2022)
  1.4.5 New England Active Pharmaceutical Ingredients(API) Status and Prospect (2012-2022)
  1.4.6 The South Active Pharmaceutical Ingredients(API) Status and Prospect (2012-2022)
  1.4.7 The Midwest Active Pharmaceutical Ingredients(API) Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Active Pharmaceutical Ingredients(API) (2012-2022)
  1.5.1 United States Active Pharmaceutical Ingredients(API) Sales and Growth Rate (2012-2022)
  1.5.2 United States Active Pharmaceutical Ingredients(API) Revenue and Growth Rate (2012-2022)

2 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS(API) MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Active Pharmaceutical Ingredients(API) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Active Pharmaceutical Ingredients(API) Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Active Pharmaceutical Ingredients(API) Average Price by Players/Suppliers (2012-2017)
2.4 United States Active Pharmaceutical Ingredients(API) Market Competitive Situation and Trends
  2.4.1 United States Active Pharmaceutical Ingredients(API) Market Concentration Rate
  2.4.2 United States Active Pharmaceutical Ingredients(API) Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Active Pharmaceutical Ingredients(API) Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS(API) SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Active Pharmaceutical Ingredients(API) Sales and Market Share by Region (2012-2017)
3.2 United States Active Pharmaceutical Ingredients(API) Revenue and Market Share by Region (2012-2017)
3.3 United States Active Pharmaceutical Ingredients(API) Price by Region (2012-2017)

4 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS(API) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Active Pharmaceutical Ingredients(API) Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Active Pharmaceutical Ingredients(API) Revenue and Market Share by Type (2012-2017)
4.3 United States Active Pharmaceutical Ingredients(API) Price by Type (2012-2017)
4.4 United States Active Pharmaceutical Ingredients(API) Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS(API) SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Active Pharmaceutical Ingredients(API) Sales and Market Share by Application (2012-2017)
5.2 United States Active Pharmaceutical Ingredients(API) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS(API) PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Active Pharmaceutical Ingredients(API) Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Active Pharmaceutical Ingredients(API) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis International
  6.2.2 Active Pharmaceutical Ingredients(API) Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis International Active Pharmaceutical Ingredients(API) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi
  6.3.2 Active Pharmaceutical Ingredients(API) Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi Active Pharmaceutical Ingredients(API) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim
  6.4.2 Active Pharmaceutical Ingredients(API) Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
  6.5.2 Active Pharmaceutical Ingredients(API) Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Teva Pharmaceutical
  6.6.2 Active Pharmaceutical Ingredients(API) Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Eli Lilly and Company
  6.7.2 Active Pharmaceutical Ingredients(API) Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Eli Lilly and Company Active Pharmaceutical Ingredients(API) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
  6.8.2 Active Pharmaceutical Ingredients(API) Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 GlaxoSmithKline Active Pharmaceutical Ingredients(API) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Merck & Co
  6.9.2 Active Pharmaceutical Ingredients(API) Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Merck & Co Active Pharmaceutical Ingredients(API) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 AbbVie
  6.10.2 Active Pharmaceutical Ingredients(API) Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AbbVie Active Pharmaceutical Ingredients(API) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Johnson & Johnson
6.12 Bayer
6.13 Sun Pharmaceutical Industries
6.14 DSM
6.15 Hisun Pharmacy
6.16 Huahai Pharmaceutical
6.17 North China Pharmaceutical Group
6.18 Shandong Lukang Pharmaceutical
6.19 Haerbin Pharmaceutical Group
6.20 Shandong Xinhua Pharmaceutical
6.21 Jiangsu Hengrui Medicine
6.22 Lonza Group
6.23 Aurobindo Pharma
6.24 Lupin
6.25 Biocon

7 ACTIVE PHARMACEUTICAL INGREDIENTS(API) MANUFACTURING COST ANALYSIS

7.1 Active Pharmaceutical Ingredients(API) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients(API)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Active Pharmaceutical Ingredients(API) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Active Pharmaceutical Ingredients(API) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS(API) MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Active Pharmaceutical Ingredients(API) Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Active Pharmaceutical Ingredients(API) Sales Volume Forecast by Type (2017-2022)
11.3 United States Active Pharmaceutical Ingredients(API) Sales Volume Forecast by Application (2017-2022)
11.4 United States Active Pharmaceutical Ingredients(API) Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Active Pharmaceutical Ingredients(API)
Figure United States Active Pharmaceutical Ingredients(API) Market Size (K Units) by Type (2012-2022)
Figure United States Active Pharmaceutical Ingredients(API) Sales Volume Market Share by Type (Product Category) in 2016
Figure Synthetic APIs Product Picture
Figure Biotech APIs Product Picture
Figure United States Active Pharmaceutical Ingredients(API) Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Active Pharmaceutical Ingredients(API) by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Disease Examples
Table Key Downstream Customer in Cardiovascular Disease
Figure CNS and Neurological Disorders Examples
Table Key Downstream Customer in CNS and Neurological Disorders
Figure Endocrinology Examples
Table Key Downstream Customer in Endocrinology
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Active Pharmaceutical Ingredients(API) Market Size (Million USD) by Region (2012-2022)
Figure The West Active Pharmaceutical Ingredients(API) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Active Pharmaceutical Ingredients(API) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Active Pharmaceutical Ingredients(API) Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Active Pharmaceutical Ingredients(API) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Active Pharmaceutical Ingredients(API) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Active Pharmaceutical Ingredients(API) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Active Pharmaceutical Ingredients(API) Sales (K Units) and Growth Rate (2012-2022)
Figure United States Active Pharmaceutical Ingredients(API) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Active Pharmaceutical Ingredients(API) Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Active Pharmaceutical Ingredients(API) Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Active Pharmaceutical Ingredients(API) Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Active Pharmaceutical Ingredients(API) Sales Share by Players/Suppliers
Figure 2017 United States Active Pharmaceutical Ingredients(API) Sales Share by Players/Suppliers
Figure United States Active Pharmaceutical Ingredients(API) Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Active Pharmaceutical Ingredients(API) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Active Pharmaceutical Ingredients(API) Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Active Pharmaceutical Ingredients(API) Revenue Share by Players/Suppliers
Figure 2017 United States Active Pharmaceutical Ingredients(API) Revenue Share by Players/Suppliers
Table United States Market Active Pharmaceutical Ingredients(API) Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Active Pharmaceutical Ingredients(API) Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Active Pharmaceutical Ingredients(API) Market Share of Top 3 Players/Suppliers
Figure United States Active Pharmaceutical Ingredients(API) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Active Pharmaceutical Ingredients(API) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Active Pharmaceutical Ingredients(API) Product Category
Table United States Active Pharmaceutical Ingredients(API) Sales (K Units) by Region (2012-2017)
Table United States Active Pharmaceutical Ingredients(API) Sales Share by Region (2012-2017)
Figure United States Active Pharmaceutical Ingredients(API) Sales Share by Region (2012-2017)
Figure United States Active Pharmaceutical Ingredients(API) Sales Market Share by Region in 2016
Table United States Active Pharmaceutical Ingredients(API) Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Active Pharmaceutical Ingredients(API) Revenue Share by Region (2012-2017)
Figure United States Active Pharmaceutical Ingredients(API) Revenue Market Share by Region (2012-2017)
Figure United States Active Pharmaceutical Ingredients(API) Revenue Market Share by Region in 2016
Table United States Active Pharmaceutical Ingredients(API) Price (USD/Unit) by Region (2012-2017)
Table United States Active Pharmaceutical Ingredients(API) Sales (K Units) by Type (2012-2017)
Table United States Active Pharmaceutical Ingredients(API) Sales Share by Type (2012-2017)
Figure United States Active Pharmaceutical Ingredients(API) Sales Share by Type (2012-2017)
Figure United States Active Pharmaceutical Ingredients(API) Sales Market Share by Type in 2016
Table United States Active Pharmaceutical Ingredients(API) Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Active Pharmaceutical Ingredients(API) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Active Pharmaceutical Ingredients(API) by Type (2012-2017)
Figure Revenue Market Share of Active Pharmaceutical Ingredients(API) by Type in 2016
Table United States Active Pharmaceutical Ingredients(API) Price (USD/Unit) by Types (2012-2017)
Figure United States Active Pharmaceutical Ingredients(API) Sales Growth Rate by Type (2012-2017)
Table United States Active Pharmaceutical Ingredients(API) Sales (K Units) by Application (2012-2017)
Table United States Active Pharmaceutical Ingredients(API) Sales Market Share by Application (2012-2017)
Figure United States Active Pharmaceutical Ingredients(API) Sales Market Share by Application (2012-2017)
Figure United States Active Pharmaceutical Ingredients(API) Sales Market Share by Application in 2016
Table United States Active Pharmaceutical Ingredients(API) Sales Growth Rate by Application (2012-2017)
Figure United States Active Pharmaceutical Ingredients(API) Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredients(API) Sales Growth Rate (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredients(API) Sales Market Share in United States (2012-2017)
Figure Pfizer Active Pharmaceutical Ingredients(API) Revenue Market Share in United States (2012-2017)
Table Novartis International Basic Information List
Table Novartis International Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis International Active Pharmaceutical Ingredients(API) Sales Growth Rate (2012-2017)
Figure Novartis International Active Pharmaceutical Ingredients(API) Sales Market Share in United States (2012-2017)
Figure Novartis International Active Pharmaceutical Ingredients(API) Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Active Pharmaceutical Ingredients(API) Sales Growth Rate (2012-2017)
Figure Sanofi Active Pharmaceutical Ingredients(API) Sales Market Share in United States (2012-2017)
Figure Sanofi Active Pharmaceutical Ingredients(API) Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Active Pharmaceutical Ingredients(API) Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Active Pharmaceutical Ingredients(API) Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company Active Pharmaceutical Ingredients(API) Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Active Pharmaceutical Ingredients(API) Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Active Pharmaceutical Ingredients(API) Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Active Pharmaceutical Ingredients(API) Revenue Market Share in United States (2012-2017)
Table Merck & Co Basic Information List
Table Merck & Co Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co Active Pharmaceutical Ingredients(API) Sales Growth Rate (2012-2017)
Figure Merck & Co Active Pharmaceutical Ingredients(API) Sales Market Share in United States (2012-2017)
Figure Merck & Co Active Pharmaceutical Ingredients(API) Revenue Market Share in United States (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Active Pharmaceutical Ingredients(API) Sales Growth Rate (2012-2017)
Figure AbbVie Active Pharmaceutical Ingredients(API) Sales Market Share in United States (2012-2017)
Figure AbbVie Active Pharmaceutical Ingredients(API) Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Bayer Basic Information List
Table Sun Pharmaceutical Industries Basic Information List
Table DSM Basic Information List
Table Hisun Pharmacy Basic Information List
Table Huahai Pharmaceutical Basic Information List
Table North China Pharmaceutical Group Basic Information List
Table Shandong Lukang Pharmaceutical Basic Information List
Table Haerbin Pharmaceutical Group Basic Information List
Table Shandong Xinhua Pharmaceutical Basic Information List
Table Jiangsu Hengrui Medicine Basic Information List
Table Lonza Group Basic Information List
Table Aurobindo Pharma Basic Information List
Table Lupin Basic Information List
Table Biocon Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredients(API)
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredients(API)
Figure Active Pharmaceutical Ingredients(API) Industrial Chain Analysis
Table Raw Materials Sources of Active Pharmaceutical Ingredients(API) Major Players/Suppliers in 2016
Table Major Buyers of Active Pharmaceutical Ingredients(API)
Table Distributors/Traders List
Figure United States Active Pharmaceutical Ingredients(API) Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Active Pharmaceutical Ingredients(API) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Active Pharmaceutical Ingredients(API) Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Active Pharmaceutical Ingredients(API) Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Active Pharmaceutical Ingredients(API) Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Active Pharmaceutical Ingredients(API) Sales Volume (K Units) Forecast by Type in 2022
Table United States Active Pharmaceutical Ingredients(API) Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Active Pharmaceutical Ingredients(API) Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Active Pharmaceutical Ingredients(API) Sales Volume (K Units) Forecast by Application in 2022
Table United States Active Pharmaceutical Ingredients(API) Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Active Pharmaceutical Ingredients(API) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Active Pharmaceutical Ingredients(API) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Active Pharmaceutical Ingredients(API) Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories